.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,083,514

« Back to Dashboard

Details for Patent: 6,083,514

Title: Polymethylpentene container for an inhalation anesthetic
Abstract:A pharmaceutical product. The pharmaceutical product includes a container constructed from a material containing polymethylpentene. The container defines an interior space. A volume of a fluoroether-containing inhalation anesthetic is contained in the interior space defined by the container.
Inventor(s): Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Flament-Garcia; Mary Jane (Gurnee, IL), Garapolo; Joan (Libertyville, IL), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Ramsay; George M. (Waukegan, IL), Rice; Patrick (Waukegan, IL), Setesak; Jeffrey (Lincolnshire, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Filing Date:Jan 09, 1998
Application Number:09/004,792
Claims:1. An inhalation anesthetic product comprising:

a container constructed from a material comprising polymethylpentene, said container defining an interior space constructed to contain therein, external to a patient's body, an inhalation anesthetic; and

a volume of sevoflurane contained in said interior space defined by said container.

2. An inhalation anesthetic product in accordance with claim 1, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said inhalation anesthetic product further comprising a cap, said cap constructed to seal said opening defined in said container, said cap constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene.

3. An inhalation anesthetic product in accordance with claim 1, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said inhalation anesthetic product further comprising a cap having an interior surface, said cap constructed to seal said opening defined in said container, said interior surface of said cap constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene.

4. An inhalation anesthetic product comprising:

a container defining an interior space constructed to contain therein, external to a patient's body, an inhalation anesthetic, said container having an interior surface adjacent to said interior space, said interior surface constructed from a material comprising polymethylpentene; and

a volume of sevoflurane contained in said container.

5. An inhalation anesthetic product in accordance with claim 4, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said inhalation anesthetic product further comprising a cap, said cap constructed to seal said opening defined in said container, said cap constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene.

6. An inhalation anesthetic product in accordance with claim 4 wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said inhalation anesthetic product further comprising a cap having an interior surface, said cap constructed to seal said opening defined in said container, said interior surface of said cap constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene.

7. A method for storing an inhalation anesthetic external to a patient's body, said method comprising the steps of:

providing a predetermined volume of sevoflurane;

providing a container defining an interior space, said container constructed from a material comprising polymethylpentene; and

placing said predetermined volume of sevoflurane in said interior space defined by said container.

8. A method for storing an inhalation anesthetic in accordance with claim 7, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said method further comprising the steps of:

providing a cap constructed to seal said opening defined in said container, said cap comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene; and

sealing said opening defined in said container with said cap.

9. A method for storing an inhalation anesthetic in accordance with claim 7, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said method further comprising the steps of:

providing a cap constructed to seal said opening defined in said container, said cap having an interior surface constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene; and

sealing said opening defined in said container with said cap.

10. A method for storing an inhalation anesthetic external to a patient's body, said method comprising the steps of:

providing a predetermined volume of sevoflurane;

providing a container defining an interior space, said container having an interior wall adjacent said interior space defined by said container, said interior wall of said container constructed from a material comprising polymethylpentene; and

placing said predetermined volume of sevoflurane in said interior space defined by said container.

11. A method for storing an inhalation anesthetic in accordance with claim 10, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said method further comprising the steps of:

providing a cap constructed to seal said opening defined in said container, said cap comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene; and

sealing said opening defined in said container with said cap.

12. A method for storing an inhalation anesthetic in accordance with claim 10, wherein said container defines an opening therein, said opening providing fluid communication between said interior space defined by said container and an external environment of said container, said method further comprising the steps of:

providing a cap constructed to seal said opening defined in said container, said cap having an interior surface constructed from a material comprising a compound selected from a group consisting of polyethylene, polyethylene napthalate and polymethylpentene; and

sealing said opening defined in said container with said cap.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc